4.6 Review

Current Knowledge about the Peritumoral Microenvironment in Glioblastoma

相关参考文献

注意:仅列出部分参考文献,下载原文获取全部文献信息。
Article Biochemistry & Molecular Biology

Insights into the Peritumoural Brain Zone of Glioblastoma: CDK4 and EXT2 May Be Potential Drivers of Malignancy

Martina Giambra et al.

Summary: Despite efforts made, glioblastoma remains a deadly primary brain cancer with no cure. The peritumoural brain zone (PBZ), the apparently normal area surrounding the tumour, has shown potential in the tumour's maintenance and progression. This study aims to better understand PBZ and identify genes that may play a role in its malignant transformation.

INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES (2023)

Article Neurosciences

Histologic Definition of Enhancing Core and FLAIR Hyperintensity Region of Glioblastoma, IDH-Wild Type: A Clinico-Pathologic Study on a Single-Institution Series

Giuseppe Broggi et al.

Summary: The extent of resection beyond the enhancing core in GBM, IDHwt is a controversial topic in neuro-oncology. This study provides a comprehensive description of the histological features of FLAIR hyperintensity regions, which are often visible beyond the conventional EC. The histological analysis reveals that FLAIR areas consist of infiltrated white matter, reactive astrogliosis with grey matter, and tumor tissue.

BRAIN SCIENCES (2023)

Review Neurosciences

The peritumoral brain zone in glioblastoma: where we are and where we are going

Martina Giambra et al.

Summary: This review provides knowledge on the oncogenic properties of the peritumoral brain zone (PBZ) in glioblastoma (GBM), highlighting potential druggable targets for more effective treatment. The review covers cellular and molecular interactions, as well as clinical aspects such as imaging details.

JOURNAL OF NEUROSCIENCE RESEARCH (2023)

Review Oncology

Surgical management of Glioma Grade 4: technical update from the neuro-oncology section of the Italian Society of Neurosurgery (SINch®): a systematic review

Tamara Ius et al.

Summary: The aim of this article is to provide an overview of the current trends and technical tools to achieve maximal safe resection in adult patients with Grade 4 Glioma. The results show that the use of Dexamethasone and avoidance of prophylaxis with anti-seizure medications are important in improving overall survival.

JOURNAL OF NEURO-ONCOLOGY (2023)

Article Oncology

Extracellular LGALS3BP: a potential disease marker and actionable target for antibody-drug conjugate therapy in glioblastoma

Beatrice Dufrusine et al.

Summary: This study demonstrates that vesicular galectin-3-binding protein (LGALS3BP) is a potential diagnostic biomarker and therapeutic target for glioblastoma multiforme (GBM). Immunohistochemical analysis shows high expression of LGALS3BP in GBM patient tissues, and the amount of vesicular LGALS3BP is increased compared to healthy donors. Furthermore, analysis of extracellular vesicles from mice with human GBM indicates that LGALS3BP can be used as a marker for liquid biopsy. An antibody-drug conjugate (ADC) targeting LGALS3BP, named 1959-sss/DM4, shows specific accumulation in tumor tissue and produces potent antitumor activity. Overall, this work provides evidence for the importance of LGALS3BP as a diagnostic biomarker and therapeutic target for GBM, warranting further validation in preclinical and clinical studies.

MOLECULAR ONCOLOGY (2023)

Review Oncology

The Role of Hypoxia and Cancer Stem Cells in Development of Glioblastoma

Tingyu Shi et al.

Summary: Glioblastoma multiforme (GBM) is a highly malignant brain tumor characterized by a small population of glioblastoma stem-like cells (GSCs) that possess self-renewal, proliferative, invasive, and tumorigenic capabilities, leading to radio- and chemoresistance. Hypoxia inducible factors (HIFs) play a crucial role in the maintenance and progression of GSCs. This review summarizes the roles of hypoxia-associated GSCs in GBM development, including hypoxia-induced signatures, genes, pathways, and metabolic alterations. The concept of the hypoxic peri-arteriolar niche of GSCs is discussed. Autophagy and potential causes of therapeutic resistance in GBM are explored, along with chemotherapeutic agents to enhance the effectiveness of chemo-, radio-, or immunotherapy. Hyperbaric oxygen therapy (HBOT) is proposed as an adjuvant therapy to reverse the hypoxic microenvironment in GBM. Overall, understanding the intricate interactions between hypoxia and GSCs can lead to the development of novel therapeutic strategies to improve GBM patient survival.

CANCERS (2023)

Review Oncology

Supramaximal versus gross total resection in Glioblastoma, IDH wild-type and Astrocytoma, IDH-mutant, grade 4, effect on overall and progression free survival: systematic review and meta-analysis

Juan F. F. Mier-Garcia et al.

Summary: This study synthesized the evidence on the impact of supramaximal resection (SMR) over gross total resection (GTR) on progression-free survival (PFS) and overall survival (OS) in Glioblastoma, IDH wild-type and Astrocytoma, IDH-mutant, grade 4. The analysis of included studies revealed significantly better clinical outcomes favoring SMR in terms of PFS and OS.

JOURNAL OF NEURO-ONCOLOGY (2023)

Review Neurosciences

Supramarginal Resection for Glioblastoma: It Is Time to Set Boundaries! A Critical Review on a Hot Topic

Francesco Guerrini et al.

Summary: The study on supra marginal resection (SMR) in patients with glioblastoma shows a positive impact on improving overall survival, while it is important to avoid potential harmful resection to prevent new neurological deficits.

BRAIN SCIENCES (2022)

Article Neurosciences

Microglia states and nomenclature: A field at its crossroads

Rosa C. Paolicelli et al.

NEURON (2022)

Review Oncology

The complex interactions between the cellular and non-cellular components of the brain tumor microenvironmental landscape and their therapeutic implications

Syed M. Faisal et al.

Summary: Glioblastoma (GBM) is an aggressive high-grade glial tumor with a universal recurrence rate, and the interaction between GBM cells and the non-cellular components in the tumor microenvironment (TME) plays a crucial role in therapy resistance and poor prognosis.

FRONTIERS IN ONCOLOGY (2022)

Article Medicine, Research & Experimental

TGFBI secreted by tumor-associated macrophages promotes glioblastoma stem cell-driven tumor growth via integrin αvβ5-Src-Stat3 signaling

Peng Peng et al.

Summary: TGFBI, specifically expressed by tumor-associated macrophages (TAMs), plays a role in promoting glioma stem cells (GSCs) maintenance and tumor growth. The exact mechanism involves integrin alpha v beta 5-Src-Stat3 signaling pathway.

THERANOSTICS (2022)

Article Clinical Neurology

FLAIRectomy in Supramarginal Resection of Glioblastoma Correlates With Clinical Outcome and Survival Analysis: A Prospective, Single Institution, Case Series

Francesco Certo et al.

Summary: The study demonstrated that EOTR based on FLAIR and 5-ALA fluorescence is feasible and provides better survival predictions. FLAIR volumetric evaluation showed larger tumor volume and stronger correlation with survival outcomes compared to T1-weighted MR images.

OPERATIVE NEUROSURGERY (2021)

Article Oncology

Differential gene expression in peritumoral brain zone of glioblastoma: role of SERPINA3 in promoting invasion, stemness and radioresistance of glioma cells and association with poor patient prognosis and recurrence

Vidya P. Nimbalkar et al.

Summary: This study molecularly characterized the peritumoral brain zone (PBZ) of glioblastoma (GBM) and investigated the pathobiology of tumor recurrence. The results showed that high expression of SERPINA3 in GBM is associated with tumor invasiveness and adverse clinical outcome.

JOURNAL OF NEURO-ONCOLOGY (2021)

Article Oncology

Growth factors contribute to the mediation of angiogenic capacity of glioma-associated mesenchymal stem cells

Qing Zhang et al.

Summary: The study revealed that TGF-beta 1 and PDGF-BB play crucial roles in mediating the angiogenic capacity of gb-MSCs by signaling through their receptors, TGF-beta 1R and PDGFR. This may provide a new therapeutic strategy for targeting the angiogenic capacity of gb-MSCs in patients with glioma.

ONCOLOGY LETTERS (2021)

Review Biochemistry & Molecular Biology

Hypoxia: The Cornerstone of Glioblastoma

Marta Domenech et al.

Summary: Glioblastoma is the most aggressive form of brain tumor in adults, with hypoxia-induced factor 1 (HIF-1) serving as an important driver of tumor progression by promoting angiogenesis, immunosuppression, and metabolic reprogramming. HIF-1 is not only regulated by oxygen levels but also by various oncogenic signaling pathways, and inhibiting the hypoxia pathway could be a crucial treatment alternative for GB patients.

INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES (2021)

Article Oncology

MRI radiomics to differentiate between low grade glioma and glioblastoma peritumoral region

Nauman Malik et al.

Summary: This study investigated the use of radiomics-based approach to distinguish between GBM PTR and LGG, showing that quantitative analysis of conventional MRI sequences can effectively differentiate between the two types of tumors.

JOURNAL OF NEURO-ONCOLOGY (2021)

Review Medicine, Research & Experimental

Role of galectin 3 binding protein in cancer progression: a potential novel therapeutic target

Emily Capone et al.

Summary: LGALS3BP, a secreted protein expressed in most human cells, has been identified as a potential therapeutic target for cancer treatment. Studies have shown that LGALS3BP plays a significant role in cancer, potentially impacting prognosis and functionality.

JOURNAL OF TRANSLATIONAL MEDICINE (2021)

Article Oncology

CBTRUS Statistical Report: Primary Brain and Other Central Nervous System Tumors Diagnosed in the United States in 2014-2018

Quinn T. Ostrom et al.

Summary: The report from CBTRUS provides the most up-to-date population-based data on primary brain tumors in the United States, including incidence rates, mortality rates, and survival rates for both malignant and non-malignant tumors.

NEURO-ONCOLOGY (2021)

Review Neurosciences

Reactive astrocyte nomenclature, definitions, and future directions

Carole Escartin et al.

Summary: The article highlights the challenges and uncertainties surrounding reactive astrocytes, advocating for comprehensive research that includes assessment of multiple molecular and functional parameters, preferably in vivo, along with multivariate statistics and determination of impact on pathological hallmarks in relevant models.

NATURE NEUROSCIENCE (2021)

Review Immunology

Current Immunotherapies for Glioblastoma Multiforme

Boyuan Huang et al.

Summary: Glioblastoma multiforme (GBM) is the most common and aggressive malignant tumor in the central nervous system. Immunotherapy has shown promising results in the treatment of GBM, but future developments will require an integrated approach with various treatment modalities and specific targeted therapies for the tumor microenvironment.

FRONTIERS IN IMMUNOLOGY (2021)

Review Neurosciences

Peritumoral Microenvironment in High-Grade Gliomas: From FLAIRectomy to Microglia-Glioma Cross-Talk

Roberto Altieri et al.

Summary: The composition and molecular signatures of the glioma core and infiltrative margins differ, with the tumor edge enriched in microglia. Microglia in HGGs play a dual role, with activation in M1 phenotype exhibiting a scavenger-tumoricidal role, while activation in M2 phenotype favoring tumor growth and infiltration. Modulation of microglia-glioma cross-talk may lead to more effective therapies.

BRAIN SCIENCES (2021)

Article Oncology

Plasma-Derived Extracellular Vesicles Reveal Galectin-3 Binding Protein as Potential Biomarker for Early Detection of Glioma

Rashmi Rana et al.

Summary: Gliomas are the most common type of malignant brain tumors with poor prognosis. Analysis of proteins in extracellular vesicles from glioma patients may provide early detection and monitoring, with LGALS3BP identified as a potential biomarker for early diagnosis.

FRONTIERS IN ONCOLOGY (2021)

Article Oncology

Quantitative mapping of individual voxels in the peritumoral region of IDH-wildtype glioblastoma to distinguish between tumor infiltration and edema

Archya Dasgupta et al.

Summary: A radiomic signature was developed to distinguish between areas of microscopic tumors and edema in the PTR of GBM, which correlates with areas of future recurrence.

JOURNAL OF NEURO-ONCOLOGY (2021)

Article Biology

Characterizing the Genomic Profile in High-Grade Gliomas: From Tumor Core to Peritumoral Brain Zone, Passing through Glioma-Derived Tumorspheres

Martina Giambra et al.

Summary: The genomic landscape of glioblastoma and its components, such as the stem cell compartment and peritumoral brain zone, is still incomplete. Research has shown the key role of stem cells in tumor maintenance and drug resistance, as well as the importance of the marginal area where tumor recurrences often occur. By analyzing the genomic profiles of different components, new specific biomarkers have been identified for potential therapies.

BIOLOGY-BASEL (2021)

Letter Oncology

Mesenchymal stem cells: are they the good or the bad?

Quintino Giorgio D'Alessandris et al.

NEURO-ONCOLOGY (2021)

Article Oncology

Glioma-Associated Stromal Cells Stimulate Glioma Malignancy by Regulating the Tumor Immune Microenvironment

Xiangming Cai et al.

Summary: The study identified a correlation between GASCs, M2 macrophages, immune checkpoints, and methylation levels of THY1 in high-grade gliomas, proposing them as potential prognostic indicators and treatment targets. Further research is needed to validate these findings.

FRONTIERS IN ONCOLOGY (2021)

Review Oncology

The 2021 WHO Classification of Tumors of the Central Nervous System: a summary

David N. Louis et al.

Summary: The fifth edition of the WHO Classification of Tumors of the Central Nervous System integrates molecular diagnostics into CNS tumor classification, introduces different approaches to tumor nomenclature and grading, and emphasizes the importance of integrated diagnoses and layered reports.

NEURO-ONCOLOGY (2021)

Review Biochemistry & Molecular Biology

Phenotypic plasticity of myeloid cells in glioblastoma development, progression, and therapeutics

Zengpanpan Ye et al.

Summary: Research suggests that targeting infiltrating myeloid cells in the tumor microenvironment may offer a novel direction for immunotherapy in improving the prognosis of patients with Glioblastoma (GBM). These myeloid cells play a crucial role in regulating GBM progression and affecting therapeutic efficacy.

ONCOGENE (2021)

Review Cell Biology

The Interplay between Glioblastoma and Its Microenvironment

Mark Dapash et al.

Summary: GBM, the most common primary brain tumor in adults, has poor prognosis due to its aggressive nature; treatments, including immunotherapies, are hindered by the complex interactions within the tumor microenvironment; understanding and manipulating the different components and pressures in the TME can lead to more targeted therapies and potentially improved patient outcomes.
Review Biotechnology & Applied Microbiology

Therapeutic Potential of Mesenchymal Stem Cells for Cancer Therapy

Abdelkrim Hmadcha et al.

FRONTIERS IN BIOENGINEERING AND BIOTECHNOLOGY (2020)

Article Neurosciences

Tumor Development and Angiogenesis in Adult Brain Tumor: Glioblastoma

Bhavesh K. Ahir et al.

MOLECULAR NEUROBIOLOGY (2020)

Review Biochemistry & Molecular Biology

Breaking through the glioblastoma micro-environment via extracellular vesicles

Thomas Simon et al.

ONCOGENE (2020)

Review Biochemistry & Molecular Biology

Antibody-Drug Conjugates: The New Frontier of Chemotherapy

Sara Ponziani et al.

INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES (2020)

Review Immunology

Molecular Heterogeneity and Immunosuppressive Microenvironment in Glioblastoma

Syreeta DeCordova et al.

FRONTIERS IN IMMUNOLOGY (2020)

Review Cell & Tissue Engineering

Cross talkbetween mesenchymal and glioblastoma stem cells: Communication beyond controversies

Adriana Bajetto et al.

STEM CELLS TRANSLATIONAL MEDICINE (2020)

Article Multidisciplinary Sciences

Glioma-initiating cells at tumor edge gain signals from tumor core cells to promote their malignancy

Soniya Bastola et al.

NATURE COMMUNICATIONS (2020)

Article Health Care Sciences & Services

Immunohistochemical Characterization of Immune Infiltrate in Tumor Microenvironment of Glioblastoma

Hassan Rahimi Koshkaki et al.

JOURNAL OF PERSONALIZED MEDICINE (2020)

Review Immunology

Treatment Progress of Immune Checkpoint Blockade Therapy for Glioblastoma

Na Zhang et al.

FRONTIERS IN IMMUNOLOGY (2020)

Review Oncology

Brain immunology and immunotherapy in brain tumours

John H. Sampson et al.

NATURE REVIEWS CANCER (2020)

Article Multidisciplinary Sciences

Tumor-associated reactive astrocytes aid the evolution of immunosuppressive environment in glioblastoma

Dieter Henrik Heiland et al.

NATURE COMMUNICATIONS (2019)

Article Chemistry, Multidisciplinary

Secreted Gal-3BP is a novel promising target for non-internalizing Antibody-Drug Conjugates

Francesco Giansanti et al.

JOURNAL OF CONTROLLED RELEASE (2019)

Article Oncology

T-Cell Exhaustion Signatures Vary with Tumor Type and Are Severe in Glioblastoma

Karolina Woroniecka et al.

CLINICAL CANCER RESEARCH (2018)

Review Immunology

Dual role of macrophage in tumor immunity

Ryota Tamura et al.

IMMUNOTHERAPY (2018)

Review Immunology

The diverse functions of the PD1 inhibitory pathway

Arlene H. Sharpe et al.

NATURE REVIEWS IMMUNOLOGY (2018)

Article Multidisciplinary Sciences

Neurotoxic reactive astrocytes are induced by activated microglia

Shane A. Liddelow et al.

NATURE (2017)

Review Immunology

CXCL14 as an emerging immune and inflammatory modulator

Jing Lu et al.

JOURNAL OF INFLAMMATION-LONDON (2016)

Review Neurosciences

The role of microglia and macrophages in glioma maintenance and progression

Dolores Hambardzumyan et al.

NATURE NEUROSCIENCE (2016)

Article Neurosciences

A polarizing question: do M1 and M2 microglia exist?

Richard M. Ransohoff

NATURE NEUROSCIENCE (2016)

Review Cell & Tissue Engineering

Glioblastoma Stem Cells Microenvironment: The Paracrine Roles of the Niche in Drug and Radioresistance

Alessia Fidoamore et al.

STEM CELLS INTERNATIONAL (2016)

Article Immunology

VEGF-A modulates expression of inhibitory checkpoints on CD8+ T cells in tumors

Thibault Voron et al.

JOURNAL OF EXPERIMENTAL MEDICINE (2015)

Article Oncology

Characterizing the peritumoral brain zone in glioblastoma: a multidisciplinary analysis

Jean-Michel Lemee et al.

JOURNAL OF NEURO-ONCOLOGY (2015)

Review Pharmacology & Pharmacy

HIF-1α pathway: role, regulation and intervention for cancer therapy

Georgina N. Masoud et al.

ACTA PHARMACEUTICA SINICA B (2015)

Article Multidisciplinary Sciences

MRI-localized biopsies reveal subtype-specific differences in molecular and cellular composition at the margins of glioblastoma

Brian J. Gill et al.

PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2014)

Review Oncology

The Definition of Primary and Secondary Glioblastoma

Hiroko Ohgaki et al.

CLINICAL CANCER RESEARCH (2013)

Article Neurosciences

Molecular definition of the pro-tumorigenic phenotype of glioma-activated microglia

Aleksandra Ellert-Miklaszewska et al.

Review Cell Biology

Carcinoma-associated fibroblasts: Non-neoplastic tumour-promoting mesenchymal cells

Urszula M. Polanska et al.

JOURNAL OF CELLULAR PHYSIOLOGY (2013)

Article Biochemical Research Methods

Proteomic analysis of glioblastomas: What is the best brain control sample?

Jean-Michel Lemee et al.

JOURNAL OF PROTEOMICS (2013)

Article Multidisciplinary Sciences

Gene Expression Profile of Glioblastoma Peritumoral Tissue: An Ex Vivo Study

Annunziato Mangiola et al.

PLOS ONE (2013)

Article Clinical Neurology

Addressing Diffuse Glioma as a Systemic Brain Disease With Single-Cell Analysis

Felix Sahm et al.

ARCHIVES OF NEUROLOGY (2012)

Article Clinical Neurology

Tumour-infiltrating T-cell subpopulations in glioblastomas

Young-Hee Kim et al.

BRITISH JOURNAL OF NEUROSURGERY (2012)

Article Medicine, Research & Experimental

TGF-β induces miR-182 to sustain NF-κB activation in glioma subsets

Libing Song et al.

JOURNAL OF CLINICAL INVESTIGATION (2012)

Article Oncology

Isolation of a new cell population in the glioblastoma microenvironment

Anne Clavreul et al.

JOURNAL OF NEURO-ONCOLOGY (2012)

Article Neurosciences

The Brain Tumor Microenvironment

Nikki A. Charles et al.

Article Clinical Neurology

Residual Tumor Cells Are Unique Cellular Targets in Glioblastoma

Martin Glas et al.

ANNALS OF NEUROLOGY (2010)

Article Clinical Neurology

Quantitative analysis of glioma cell invasion by diffusion tensor imaging

Zhaoxia Deng et al.

JOURNAL OF CLINICAL NEUROSCIENCE (2010)

Review Pathology

Genetic pathways to primary and secondary glioblastoma

Hiroko Ohgaki et al.

AMERICAN JOURNAL OF PATHOLOGY (2007)

Article Oncology

A1 adenosine receptors in microglia control glioblastoma-host interaction

Mchael Synowitz et al.

CANCER RESEARCH (2006)

Article Biochemistry & Molecular Biology

Extensive modulation of a set of microRNAs in primary glioblastoma

SA Ciafrè et al.

BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS (2005)

Review Neurosciences

Microglia function in brain tumors

JJ Watters et al.

JOURNAL OF NEUROSCIENCE RESEARCH (2005)

Article Biochemistry & Molecular Biology

Elevated JNK activation contributes to the pathogenesis of human brain tumors

MA Antonyak et al.

ONCOGENE (2002)

Review Endocrinology & Metabolism

Anti-inflammatory cytokines: Expression and action in the brain

L Vitkovic et al.

NEUROIMMUNOMODULATION (2001)